VENUSREM

The stock has been placed in Additional Surveillance Measure (ASM) list LTASM - IV (16).

Venus Remedies Ltd.

NSE: VENUSREM

BSE: 526953

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1,719.50+17.0 (+1.00%)

10 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

95.7 / 100

Value Score

57.7 / 100

Price Momentum Score

95.0 / 100

QVM Score

98.7 / 100

Key Metrics

Market Cap

2298.46

P/E (TTM)

22.36

P/B

3.46

P/S (TTM)

2.99

EV/EBITDA

14.98

CAPE (5Y)

47.02

ROE (TTM)

16.79

ROCE (TTM)

19.63

ROA (TTM)

13.10

Avg 3Y ROE

10.48

Earnings 3Y CAGR

56.99

Sales 3Y CAGR

11.48

Sales 5Y CAGR

7.02

Debt/Equity

0.02

Consensus TP

326.00

Strong Buy %

Promoter Holding

41.76

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Venus Remedies Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is reasonably valued and PE TTM is at a discount to industry median

PE TTM of 22.36 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -27.94%

What is P/E Ratio?

Median: 31.03

Value 22.36

-215.443203.67

Strong price momentum

Price Momentum score of 95.0 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

95.0 / 100

High and improving ROE

The company reported strong ROE of 16.79% for 12-month ended 31 Mar 2026 and ROE improved by 814 bps from 1 year ago

What is ROE (FY)?

High and improving operating margin

The company reported strong operating margin of 15.8% for 12-month ended 31 Mar 2026 and operating margin improved by 947 bps from 1 year ago

What is Operating profit margin?

Moderate revenue growth and above median growth of industry

The company delivered moderate revenue growth of 18.79% for 12-month ended 31 Mar 2026 and the growth was 7.55 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 11.24

Value 18.79

-82.35114662

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 126.83% for 12-month ended 31 Mar 2026 and the growth was 118.71 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.02 as on 31 Mar 2026 and Debt to Equity increased marginally by 0.02 in the last 1 year

What is Debt to Equity?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 65.7 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

65.7 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Venus Remedies Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Venus Remedies Ltd. Shareholding Pattern

Quarterly breakdown of Venus Remedies Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	35.89	35.89	35.89	35.89	35.89	40.81	40.81	40.81	40.81	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76
Indian Promoter	35.89	35.89	35.89	35.89	35.89	40.81	40.81	40.81	40.81	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76	41.76
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.04	0.04	0.04	0.04	0.04	0.04	0.10	0.28	0.33	0.96	1.13	1.07	1.00	0.98	1.03	1.59	1.48	1.06	1.18	1.11	1.34	2.35	2.61	3.29	4.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.04	0.04	0.04	0.04	0.04	0.04	0.10	0.28	0.33	0.96	1.13	1.07	1.00	0.98	1.03	1.59	1.48	1.06	1.18	1.11	1.34	2.25	1.86	2.25	2.80
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.11	0.75	1.03	1.20
Non-Institution	64.07	64.07	64.07	64.07	64.07	59.15	59.09	58.91	58.86	57.28	57.11	57.17	57.24	57.26	57.21	56.65	56.76	57.18	57.06	57.13	56.90	55.89	55.63	54.96	54.24
Bodies Corporate	3.38	2.62	2.28	2.16	2.77	2.40	2.37	2.08	2.07	2.18	1.89	2.04	1.68	2.03	1.92	3.16	3.01	3.07	4.44	4.29	1.92	2.67	2.78	2.14	2.33
Others (incl. Retail) No. of shareholders	60.69 17,058	61.45 16,588	61.79 15,337	61.91 14,639	61.30 13,712	56.75 13,729	56.72 16,496	56.83 18,097	56.79 19,828	55.10 21,052	55.22 21,868	55.13 22,103	55.56 21,592	55.23 20,374	55.29 19,151	53.49 19,425	53.75 19,795	54.11 19,500	52.62 19,436	52.84 19,649	54.98 19,864	53.22 19,185	52.85 17,610	52.82 18,456	51.91 18,244

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Venus Remedies Ltd. is not part of any tracked index.

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Venus Remedies Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
PAWAN CHAUDHARY Promoter	May-2022	Market Purchase (Acquisition) 31st May 2022	11.87 %	₹ 217.31	1.27 lac	₹ 2.76 cr

Corporate Actions

History of Venus Remedies Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 10/share
Record date: 7th Aug 2026Ex-date: 7th Aug 2026
Announced on: 26th May 2026
Dividend₹ 3/share
Record date: 24th Sep 2013Ex-date: 23rd Sep 2013
Announced on: 20th May 2013
Dividend₹ 3/share
Record date: 22nd Sep 2012Ex-date: 20th Sep 2012
Announced on: 21st Jun 2012
Dividend₹ 3/share
Record date: 24th Sep 2011Ex-date: 22nd Sep 2011
Announced on: 26th Jul 2011
Dividend₹ 3/share
Record date: 24th Sep 2010Ex-date: 23rd Sep 2010
Announced on: 31st Jul 2010

Company Profile

Overview of Venus Remedies Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Venus Remedies Limited is a research-driven pharmaceutical company. The Company is a global injectable manufacturer. It manufactures products catering to critical care segments such as antimicrobial resistance, anti-cancer, Anti-infective, Neurology, Skin and Wound Care, and Pain Management. With a ...

Key personnel

Ms. Neha Kodan

Compliance Officer, Company Secretary

Mr. Pawan ChaudharyD

Chairman of the Board, Chief Financial Officer, Managing Director

Dr. Manu ChaudharyD

Joint Managing Director, Whole Time Director

Mr. Peeyush JainD

Deputy Managing Director, Whole-Time Director

Mr. Akshansh ChaudharyD

Additional Whole Time Director

Mr. Saransh ChaudharyD

Additional Whole Time Director

Mr. Ashutosh JainD

Whole-time Executive Director

Dr. Gurminder Singh BediD

Additional Non-Executive Independent Director

View all

Incorporated on

15 Sep 1989

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

15 Feb 1995

Free Float

68,68,250

Website

https://www.venusremedies.com/

Phone no.

+911722933090

Address

PLOT 51-52, INDUSTRIAL AREA, PHASE-1, PANCHKULA, , 134113, India

Frequently Asked Questions

What is the current share price of Venus Remedies Ltd.?

The current share price of Venus Remedies Ltd. is ₹ 1,719.50 as of 10 Jul 2026.

What is the market capitalisation of Venus Remedies Ltd.?

The market capitalisation of Venus Remedies Ltd. stands at ₹ 2,298.46 Cr.

What is the PE ratio of Venus Remedies Ltd.?

The Price-to-Earnings (PE) ratio of Venus Remedies Ltd. is 22.36 as of the latest trailing twelve months data.

What is the ROE and ROCE of Venus Remedies Ltd.?

Venus Remedies Ltd. has a Return on Equity (ROE) of 16.79% and a Return on Capital Employed (ROCE) of 19.63% as per the latest financial reports.

What is the 52-week high and low of Venus Remedies Ltd.?

The 52-week high of Venus Remedies Ltd. is - and the 52-week low is -.

What is the dividend yield of Venus Remedies Ltd.?

The dividend yield of Venus Remedies Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Venus Remedies Ltd.?

Foreign Institutional Investors (FII) hold 2.80%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 51.91% of Venus Remedies Ltd. shares.

What sector does Venus Remedies Ltd. belong to?

Venus Remedies Ltd. operates in the Healthcare sector.

What is the beta of Venus Remedies Ltd.?

The beta of Venus Remedies Ltd. is 0.78, indicating its price volatility relative to the broader market. Over the past 1 year, Venus Remedies Ltd. has delivered an absolute return of 275.03%.

What is the RSI of Venus Remedies Ltd.?

The 14-day Relative Strength Index (RSI) of Venus Remedies Ltd. is 54.91, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Venus Remedies Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Venus Remedies Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile

Corporate Actions

Holdings and Presence